Member Info for Paul2566

A little harsh and to the point, but not entirely untrue.
On the rare occasion I dabble in this type of investment I have tended to see the same general theme on chat forums.
I believe, and may be wrong, that this type of investment has a tendancy to attract naieve investors who think they are going to get rich quick. I'm not sure they fully appreciate the risk involved, and have little or no understanding of investment risk strategy. I suspect they get to a point where they are heavily weighted in risky stocks or worse still go all in on one stock. I can't say I don't feel sympathy for them. The unfortunate thing is they may well sell at a loss only to repeat their mistake on the next big thing.
I keep dripping on that this is a very high risk investment, but thats just not what investors want to hear. I don't think this is much better than a flip of the coin at the moment. This is the only investment I hold where I believe there is a real possibility I could lose 100% of my investment. But I can see the potential upside, but potential can be like a puff of smoke in a strong wind.
We do need to reach break even in the next 12months or so, but that is just the first milestone, and only puts a bandage on the wound. We then need to see profits. If MGC can achieve that it may go on to be worth holding. Again I emphasise that IMHO this is not a stock for novice investors with limited assets.

Investors should do what they feel is right for them. Bear in mind pharma stocks spend a lot on R&D, which takes years to recover through sales, and this particular type of pharma is new to the market, so I suspect large investors are still unconvinced. It remains a highly speculative investment, and its unlikly we will see a big SP rise anytime soon, unless based on sentiment. SP rise based on sentiment alone tends not to last and IMHO does more harm than good. I've mentally written off my investment and will hold for what could be medium to long term reward, i.e. 5 to 10 years. If the SP is low and I consider there is news worthy of re-evaluating my position, I may still buy more shares, although I very much doubt it as I don't intend this stock to exceed 1% of my investment portfolio with MXC cash flow as it stands. However with negative news I may well re-evaluate my position and move the money elsewhere as others already have, I'm just not there yet.
I would only caution don't let impatience or sentiment lead decisions. Positive sentiment and negative sentiment are two sides of the same dirty coin, which I appreciate can benefit savy short term traders. I've found day trading is not for me. As indicated by others, there are other stocks with far lower risks which will make money, and that is also where 99% of my other investments lay. I have found over the years that if I find myself concerned about my investments, its because I'm investing outside my acceptable area of risk. Risk being a very individual thing based on personal circumstances. To those who have sold I wish you good fortune and certainly don't suggest you have done the wrong thing.

The last 2 large trades are marked as LRGS, not sure what that means. But those two trades have a total volume of 700,000 shares.

I agree that medium to long term this 'MAY' be a winner, however I diissagree in that this is the definition of a high risk investment.
The company has yet to see a profit and money continues to flow out the door at a far greater rate than it comes in. There are a great number of shares in issue and the main interest at the moment remains with small investors which will not move the market. If you just examine the volumes today, the vast majority are below 10,000 (thats volume not value).
Pharma stocks are always a little tricky by nature, with a small cap like MXC this is only compounded.
As far as fundementals go they don't have much in their favour. Its a play based on potential promised, high risk with potential high reward. No such thing as a free lunch.

I believe this news although not earth shattering is good enough to warrant a small increase in my holding. I have purchased a further 88087 shares @ 2.62p. I still view this as a very high risk investment and it remains a very small percentage of my overall investments. I would still not advise investing any more in this stock than you are willing to lose.

On face value this appears to be very good news indeed. I am not sure it will move the SP much in isolation, however if in the following months it develops more sales or other countries follow suit then I think we will see a lot more investor interest from bigger players, and that is what the SP needs, not just small investors like us.

And the band played on.

The funding from Mercer is what gives them till about April to turn things around, if Mercer decides not to invest the additional funds, this time-frame may reduce. There is currently a lot of cash going out the door each month and in proportion, not a lot coming in. Lets hope this changes.

My thoughts are that by the end of this financial year one of two things will happen.
There will be a considerable increase in funds generated from sales/contracts, or Mgc Pharma will cease trading. I do not think they will be able to raise further capital which will be sufficient to allow trading beyond that time frame.
I'm not saying they are dead in the water yet, but I do believe this is a make or break year for the company.
I would obviously like the company to do well, but I also won't be surprised if the outcome is less than ideal.

No problem, not trying to be a smart arse, it does get complicated.
It was Erin Resources Ltd, but changed its name to MGC Pharmaceuticles Ltd in 2015, although strangely MGC was actually formed in 2014, so I'm not sure what happened there. It listed on ASX and as we know is now also listed on LSE.

There was an MXC Capital Ltd listed on aim but with the ticker MXCP and was nothing to do with MGC Pharma Ltd ticker MXC.

I must confess I didn't realise MXC had ever been listed on AIM.

Filter and move on.

:) Same here sea of green

Its served me very well over a lot of years and allowed me to retire early in comfort.
People can make big wins with a gamble, but many more lose, and the odds are very much against you.
But good luck to you.

To use one of my favorite WB quotes, 'Price is what you pay, value is what you get'.
With MXC the difference between the two is too great to consider a buying opportunity.
Cheap isn't value I'm afraid.

You may be correct, however I will not be chasing this SP down without some solid positive results. Notwithstanding that I think we may see this down to 2.5p. If it falls below 2p, I think its pretty much game over. I am now banking on sentiment over substance, if there is some very positive news, the SP may well rise in the short term on investor sentiment before falling back. Its happend before, and if timed correctly I might yet make a small profit.

I suspect you mean down

Same boat as you. I bought this knowing it was a huge gamble so I can't complain. Fortunately knowing this I invested very lightly, and have more or less written off the money. I expected this to fall into the 2's again, but expected it to begin to rise over the next 6 to 12 months. As the days pass I become more confident in the falling trend and less confident in the rise. My main concerns are that the trials of the Covid drug are very small, most companies like GSK use 20,000 to 30,000 subjects for phase 2 trials. The second is that MXC has been trading for quite a while on ASX before being listed on LSE, and has yet to turn a profit. Still I'll let the money ride and see where the ball lands.

Will it make a profit ?????????????